SetPoint Medical today announced the first patients in Chicago have been treated with the SetPoint System, an FDA-approved neuroimmune modulation therapy for adults living with moderately-to-severely ...
Software companies’ pitch to investors could use an upgrade. Once a favorite of Wall Street, software stocks have been sliding lately, with investors increasingly concerned about how the sector could ...
Only four months after IO Biotech decided to halve its head count, the Danish biotech is already considering whether it must resort to further layoffs. In September, IO received a knock-back from the ...
Setpoint’s acquisition of inTENT Fulfillment will add experienced leaders and broaden ratings agency approvals for its asset-backed finance platform. AI Summary Setpoint, an operating system for asset ...
NEW YORK--(BUSINESS WIRE)--Setpoint, the operating system for asset-backed finance, today announced that it has signed an agreement to acquire inTENT Fulfillment, a specialized loan diligence and ...
Publication of 12-month outcomes reinforces SetPoint Medical’s pioneering role in advancing neuroimmune modulation as a new treatment paradigm for rheumatoid arthritis (RA) VALENCIA, Calif.--(BUSINESS ...
SetPoint System® is first-of-its-kind neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis SetPoint Medical, a commercial-stage medical ...
Trapped in a gravitational push and pull between Jupiter and other Jovian moons, Io is constantly being stretched and compressed. Heat generated by these contortions has melted pockets of the moon's ...
The leading capital markets infrastructure platform introduces a certification to verify collateral integrity across lenders and borrowers. In the wake of the high-profile collapses of Tricolor and ...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today announced that the U.S. Food and Drug ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Two software engineering firms ...
The first-ever neuroimmune modulation implant has been approved for people with moderate to severe rheumatoid arthritis (RA) who haven't found relief with traditional medications. It's a potentially ...